2 ms·
The problem, yet again, is quarterly earnings reports. It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of
by JustSomeNobody 11y ago
The problem, yet again, is quarterly earnings reports.
It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.
Fixing patents, wouldn't necessarily fix this problem.
- ekianjo 11y ago> It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices. you don't raise prices on drugs that easily, Prices changes are heavily regulated as well.
- judemelancon 11y agoI am aware of no such regulation in the USA. Are you?